Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
Linked as:
Extract
Neurim Pharmaceuticals (1991) Ltd v The Comptroller-General of Patents
No longer available (Autolink)
See the full content of this document
Core Citations
CONSIDERS
RESUELVE RECURSO
CONSIDERS
CITED in
REFERRED in
REPORTED OPINION OF in
CONSIDERED in
This document cites
- Yissum Research and Development Company of the Hebrew University of Jerusalem v Comptroller-General of Patents
- Council Regulation (EEC) No 1768/92 of 18 June 1992 concerning the creation of a supplementary protection certificate for medicinal products
- Directive 2001/83/EC of the European Parliament and of the Council of 6 November 2001 on the Community code relating to medicinal products for human use
- Council Directive 65/65/EEC of 26 January 1965 on the approximation of provisions laid down by Law, Regulation or Administrative Action relating to proprietary medicinal products
- Regulation (EC) No 726/2004 of the European Parliament and of the Council of 31 March 2004 laying down Union procedures for the authorisation and supervision of medicinal products for human and veterinary use and establishing a European Medicines Agency (Text with EEA relevance)Text with EEA relevance
